When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMY - Along With FDA Clinical Hold Being Lifted Xencor Has Other Promising Drugs
Astellas Pharma Inc. ADR
Xencor (XNCR) was able to get the FDA to remove a clinical hold for its program using XmAb14045 to treat patients with relapsed/refractory acute myeloid leukemia. This is a big win for the company because many months ago, this program was put at a standstill after the FDA had put a partial clinical hold due to some safety issues that 2 patients had experienced. This gets the program back on track with only a few modifications necessary. The biotech also has a more advanced clinical product known as obexelimab to treat patients with